Elevated Serum Megakaryocyte Potentiating Factor as a Predictor of Poor Survival in Patients with Mesothelioma and Primary Lung Cancer

BACKGROUND: There is an urgent need for a companion assay to work with mesothelin-targeted therapeutic agents and for noninvasive and accurate prognostication of malignant mesothelioma (MM) patients. We report the development and validation of a blood-based assay for megakaryocyte potentiating facto...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Appl Lab Med
Главные авторы: Yu, Yunkai, Ryan, Bríd M., Thomas, Anish, Morrow, Betsy, Zhang, Jingli, Kang, Zhigang, Zingone, Adriana, Onda, Masanori, Hassan, Raffit, Pastan, Ira, Cao, Liang
Формат: Artigo
Язык:Inglês
Опубликовано: 2018
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201267/
https://ncbi.nlm.nih.gov/pubmed/30370398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1373/jalm.2017.025015
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы